WHY IT MATTERS: If drug testing standards are not updated to reflect the legal complexity of hemp and medical cannabis, patients following their physician’s recommendations could face wrongful termination, DUI charges, or loss of professional licenses. CLINICAL OVERVIEW: Federal agencies are raising concerns about the reliability of drug tests in distinguishing between medical cannabis use and hemp-derived CBD products, which presents a significant challenge for patients, employers, and legal systems. Because both hemp and cannabis can produce detectable THC metabolites, standard immunoassay screening tests cannot reliably differentiate between incidental hemp exposure and intentional cannabis use.
Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW
WHY IT MATTERS: If you are a medical cannabis patient who drives, understanding the specific timing and formulation of your medication is critical to both your legal safety and your actual ability to operate a vehicle without impairment. CLINICAL OVERVIEW: Research examining driving behaviors among medical cannabis patients raises important questions about how THC affects psychomotor function, reaction time, and judgment at various doses and time points after consumption. The relationship between measured THC levels and actual impairment is complex, as tolerance, route of administration, and individual pharmacokinetics all influence functional capacity behind the wheel.